Plain English Breakdown
The plain English breakdown is still being put together. The official documents below are already here.
Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.
SF0100 • 2015
AN ACT relating to the controlled substances prescription tracking program; amending the timeframe for reporting prescriptions of controlled substances as specified; repealing the sunsetted pilot program; and providing for an effective date.
This bill passed the Legislature and reached final enactment based on the latest official action.
The plain English breakdown is still being put together. The official documents below are already here.
These notes stay tied to the official amendment files and metadata from the legislature.
Standing Committee • SJudiciary
Plain English: Adopted Standing Committee by SJudiciary
Assigned Chapter Number
Governor Signed SEA No. 0049
H Speaker Signed SEA No. 0049
S President Signed SEA No. 0049
Assigned Number SEA No. 0049
H 3rd Reading:Passed 56-2-2-0-0
H 2nd Reading:Passed
H COW:Passed
H Placed on General File
Judiciary:Recommend Do Pass 9-0-0-0-0
H Introduced and Referred to H01 - Judiciary
H Received for Introduction
S 3rd Reading:Passed 29-0-1-0-0
S 2nd Reading:Passed
S COW:Passed
Amendment Adopted
S Placed on General File
Judiciary:Recommend Amend and Do Pass 5-0-0-0-0
S Introduced and Referred to S01 - Judiciary
S Received for Introduction
Bill Number Assigned
Summary for LSO115 Bill No.: SF0100 Effective : 1/1/2016 LSO No.: 15LSO-0467 Enrolled Act No.: SEA 49 Chapter No.: 135 Prime Sponsor: Esquibel, F. Catch Title: Prescription drug monitoring program-amendments. Subject: Prescription drug tracking Summary/Major Elements: This bill amends the prescription drug tracking program as follows: All prescriptions for schedule II, III and IV controlled substances dispensed by any retail pharmacy must be reported to the B oard of P harmacy no later than the close of business on the business day immediately following the day the controlled substance was dispensed. Under current law, information obtained through the controlled substance prescription tracking program is confidential and may not be released except in limited circumstances. This bill amended one of the exception s to allow the B oard of P harmacy to not only release information to practitioners and pharmacist s but to their appointed delegates when the release of the information may be of assistance in preventing or avoiding inappropriate use of controlled substances . This bill also repeal s provisions related to the sunsetted pilot program . The above summary is not an official publication of the Wyoming Legislature and is not an official statement of legislative intent. While the Legislative Service Office endeavored to provide accurate information in this summary, it should not be relied upon as a comprehensive abstract of the bill.
ORIGINAL Senate File No . SF0100 ENROLLED ACT NO. 49, SENATE SIXTY-THIRD LEGISLATURE OF THE STATE OF WYOMING 2015 General Session AN ACT relating to the controlled substances prescription tracking program; amending the timeframe for reporting prescriptions of controlled substances as specified; repealing the sunsetted pilot program; and providing for an effective date. Be It Enacted by the Legislature of the State of Wyoming: Section 1 . W.S. 35 ‑ 7 ‑ 1060(b) and (c)(i) is amended to read: 35 ‑ 7 ‑ 1060 . Controlled substances prescription tracking program. (b) All prescriptions for schedule II, III and IV controlled substances dispensed by any retail pharmacy licensed by the board shall be filed with the board electronically or by other means required by the board no more than seven (7) days after dispensed . later than the close of business on the business day immediately following the day the controlled substance was dispensed . The board may require the filing of other prescriptions and may specify the manner in which the prescriptions are filed. (c) The tracking program shall not be used to infringe on the legal use of a controlled substance. Information obtained through the controlled substance prescription tracking program is confidential and may not be released and is not admissible in any judicial or administrative proceeding, except as follows: (i) The board may release information to practitioners and practitioner appointed delegates and to pharmacists and pharmacist appointed delegates when the release of the information may be of assistance in preventing or avoiding inappropriate use of controlled substances; Section 2 . W.S. 35 ‑ 7 ‑ 1061 and 35 ‑ 7 ‑ 1062 are repealed. Section 3 . This act is effective January 1, 2016 . (END) Speaker of the House President of the Senate Governor TIME APPROVED: _________ DATE APPROVED: _________ I hereby certify that this act originated in the Senate . Chief Clerk 1